Magnitude Of Depression And Its Associated Factors Among Peoples Living With Hiv/Aids Who Were On Anti Retro Viral Therapy Follow Up At Public Health Facilities In Woliso Town, Oromia, Ethiopia, 2024

Abstract

Background: Depression is the most prevalent mental health disorder among people living with Human immune virus. People living with HIV/AIDS face different challenges, including HIVrelated perceived stigma, lack of social support and also depression. Depression is highly prevalent among HIV-positive patients, still underdiagnosed and undertreated. Identifying magnitude of depression and its associated factors among living with Human immune virus / Acquired immune deficiency syndrome plays a vital role to reduce its effect. Objective: The aim of this study was to assess magnitude of depression and its associated factors among Human immune virus / Acquired immune deficiency syndrome on Anti-retroviral therapy follow up at public health facilities in woliso town, Oromia, Ethiopia, 2024 Methods: Institutional based cross-sectional study was conducted from February 01 to 30, 2024 among 415 Human immune virus / Acquired immune deficiency syndrome infected people in woliso town. Simple random sampling technique was used. Data were collected through interview using standardized questionnaire. Frequency, mean and median was used to summarize descriptive data. In bi-variable logistic regression analysis variables with p-value less than 0.25 was considered as candidate variables for multi-variable analysis. Adjusted Odds Ratios and 95% confidence intervals were computed to see the strength of association and p-value of less than 0.05 was used to identify statistically significant factors on multi-variable logistic regression. Results: A total of 415 participated were involved in the study which makes 100% response rate. The magnitude of depression among people living with Human immune virus was 38.1% (95% CI: 33- 42.7%). Opportunistic infection (AOR = 3.14, 95% CI 1.92-5.13), poor medication adherent to Anti-retroviral therapy (AOR = 2.4, 95% CI 1.53-3.78), those experienced Human immune virus related stigma (AOR = 3.09, 95% CI 1.95-4.9) and poor social support (AOR = 3.61, 95% CI 1.39- 9.39) had statistically significant association with depression among people living with Human immune virus / Acquired immune deficiency syndrome. Conclusions: The magnitude of depression among peoples with HIV/AIDS and on ART follow up in Woliso town was high. Having poor social support, Human immune virus -related perceived stigma, opportunistic infection and poor medication adherence had statistically significant association with depressive symptom. Close follow-up for adherence for ART medication, prevention of stigma and opportunistic infection should be strengthened